Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Inflammatory Breast Neoplasms × Microarray Analysis × Clear all

Sponsor

Conditions

Breast Neoplasms 4 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, T-Cell, Peripheral 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma, Follicular 2 Lymphoma, B-Cell, Marginal Zone 2 Immunoblastic Lymphadenopathy 2 Esophageal Neoplasms 2 Burkitt Lymphoma 2 Adenocarcinoma Of Esophagus 2 Waldenstrom Macroglobulinemia 1 Triple Negative Breast Neoplasms 1 Thrombocytopenia 1 Sezary Syndrome 1 Sarcoma 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Osteosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasms, Plasma Cell 1 Myelodysplastic Syndromes 1 Mycosis Fungoides 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma 1

Interventions

Cyclophosphamide 11 Doxorubicin 7 Trastuzumab 6 Paclitaxel 6 Taxes 5 Radiotherapy 4 Epirubicin 4 Docetaxel 4 Carboplatin 4 Albumin-Bound Paclitaxel 4 pembrolizumab 3 Melphalan 3 pertuzumab 2 eribulin 2 Thiotepa 2 Tamoxifen 2 Peripheral Blood Stem Cell Transplantation 2 Lapatinib 2 Fluorouracil 2 Filgrastim 2 130-nm albumin-bound paclitaxel 2 trastuzumab biosimilar HLX02 1 talimogene laherparepvec 1 sargramostim 1 ruxolitinib 1 romidepsin 1 pazopanib 1 nintedanib 1 neratinib 1 grapiprant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡